Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineImmuPharma collapses on trial failure
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Big News
- JD Sports is still fighting fit
- ImmuPharma collapses on trial failure
- British Airways owner eyes takeover of Norwegian Air
- Apollo stalks FirstGroup with takeover interest
- Pound pushes to highest level since Brexit vote
- Cyber security firm Avast set for £2.8bn IPO
- Activist investor Elliott rumoured to have Micro Focus in its sights
- Costa spin-off calls at Whitbread gain momentum
